Nuzenio

Fda Clears

Fda Clears news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 22 publisher sources 100/100 entity strength

Latest news

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - NovartisNovartis · Sat, 08 Aug 2026 12:24:46 GMT FDA Approves First mRNA Flu Vaccine for Adults 50 and Older - Everyday HealthEveryday Health · Fri, 07 Aug 2026 22:46:46 GMT FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMT FDA Approves RP1 Plus Nivolumab for Advanced Melanoma - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 19:11:16 GMT FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 07 Aug 2026 18:55:26 GMT FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 07 Aug 2026 18:07:29 GMT FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - The American Journal of Managed CareThe American Journal of Managed Care · Fri, 07 Aug 2026 16:51:52 GMT FDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMT

Timeline

Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis

Fri, 07 Aug 2026 22:46:46 GMTFDA Approves First mRNA Flu Vaccine for Adults 50 and Older - Everyday Health

Fri, 07 Aug 2026 20:06:51 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare Executive

Fri, 07 Aug 2026 19:11:16 GMTFDA Approves RP1 Plus Nivolumab for Advanced Melanoma - Dermatology Times

Fri, 07 Aug 2026 18:55:26 GMTFDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance - The American Journal of Managed Care

Fri, 07 Aug 2026 18:07:29 GMTFDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch - The American Journal of Managed Care

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

FDA11 live mentions The American Journal6 live mentions First4 live mentions Anti4 live mentions Replimune4 live mentions Approves First3 live mentions Managed Healthcare Executive3 live mentions Managed Care FDA3 live mentions Managed Care The3 live mentions American Journal3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fda Clears.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

22 distinct publisher/source names are currently connected to this entity page.